PMID- 23686138 OWN - NLM STAT- MEDLINE DCOM- 20140206 LR - 20211021 IS - 1476-5403 (Electronic) IS - 1350-9047 (Print) IS - 1350-9047 (Linking) VI - 20 IP - 8 DP - 2013 Aug TI - Interaction between the TP63 and SHH pathways is an important determinant of epidermal homeostasis. PG - 1080-8 LID - 10.1038/cdd.2013.41 [doi] AB - Deregulation of the hedgehog (HH) pathway results in overexpression of the GLI target BCL2 and is an initiating event in specific tumor types including basal cell carcinoma of the skin. Regulation of the HH pathway during keratinocyte differentiation is not well understood. We measured HH pathway activity in response to differentiation stimuli in keratinocytes. An upregulation of suppressor of fused (SUFU), a negative regulator of the HH pathway, lowered HH pathway activity and was accompanied by loss of BCL2 expression associated with keratinocyte differentiation. We used in vitro and in vivo models to demonstrate that DeltaNp63alpha, a crucial regulator of epidermal development, activates SUFU transcription in keratinocytes. Increasing SUFU protein levels inhibited GLI-mediated gene activation in suprabasal keratinocytes and promoted differentiation. Loss of SUFU expression caused deregulation of keratinocyte differentiation and BCL2 overexpression. Using in vivo murine models, we also provide evidence of GLI-mediated regulation of the TP63 pathway. p63 expression appears essential to establish an optimally functioning HH pathway. These observations present a regulatory mechanism by which SUFU acts as an interacting node between the HH and TP63 pathways to mediate differentiation and maintain epidermal homeostasis. Disruption of this regulatory node can be an important contributor to multistep carcinogenesis. FAU - Chari, N S AU - Chari NS AD - Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. FAU - Romano, R A AU - Romano RA FAU - Koster, M I AU - Koster MI FAU - Jaks, V AU - Jaks V FAU - Roop, D AU - Roop D FAU - Flores, E R AU - Flores ER FAU - Teglund, S AU - Teglund S FAU - Sinha, S AU - Sinha S FAU - Gruber, W AU - Gruber W FAU - Aberger, F AU - Aberger F FAU - Medeiros, L J AU - Medeiros LJ FAU - Toftgard, R AU - Toftgard R FAU - McDonnell, T J AU - McDonnell TJ LA - eng GR - R01 CA160394/CA/NCI NIH HHS/United States GR - U01 CA105345/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130517 PL - England TA - Cell Death Differ JT - Cell death and differentiation JID - 9437445 RN - 0 (Hedgehog Proteins) RN - 0 (Phosphoproteins) RN - 0 (Proto-Oncogene Proteins c-bcl-2) RN - 0 (Repressor Proteins) RN - 0 (Shh protein, mouse) RN - 0 (Sufu protein, mouse) RN - 0 (Trans-Activators) RN - 0 (Trp63 protein, mouse) RN - 114100-40-2 (Bcl2 protein, mouse) SB - IM MH - Animals MH - Cell Differentiation/physiology MH - Cell Line MH - Cell Proliferation MH - Cell Survival/physiology MH - Cells, Cultured MH - *Epidermal Cells MH - Epidermis/physiology MH - Female MH - Hedgehog Proteins/*physiology MH - Homeostasis/*physiology MH - In Vitro Techniques MH - Keratinocytes/*cytology/physiology MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Inbred CBA MH - Mice, Knockout MH - Models, Animal MH - Phosphoproteins/deficiency/genetics/*physiology MH - Proto-Oncogene Proteins c-bcl-2/physiology MH - Repressor Proteins/physiology MH - Signal Transduction/*physiology MH - Trans-Activators/deficiency/genetics/*physiology PMC - PMC3705600 EDAT- 2013/05/21 06:00 MHDA- 2014/02/07 06:00 PMCR- 2014/08/01 CRDT- 2013/05/21 06:00 PHST- 2012/10/09 00:00 [received] PHST- 2013/03/06 00:00 [revised] PHST- 2013/04/08 00:00 [accepted] PHST- 2013/05/21 06:00 [entrez] PHST- 2013/05/21 06:00 [pubmed] PHST- 2014/02/07 06:00 [medline] PHST- 2014/08/01 00:00 [pmc-release] AID - cdd201341 [pii] AID - 10.1038/cdd.2013.41 [doi] PST - ppublish SO - Cell Death Differ. 2013 Aug;20(8):1080-8. doi: 10.1038/cdd.2013.41. Epub 2013 May 17.